NBTK.F Invesco NASDAQ Biotech UCITS ETF

ETF Healthcare Equity Invesco Investment Management Limited Frankfurt Exchange
- EUR
No recent price
Total assets
561M
Expense ratio
0.39%
Dividend yield
0.87%
1-year return
+43.59%
Holdings
1
Since
2014

Fund data as reported by the issuer, updated Nov 11, 2026. Total assets are in the fund's base currency.

What does NBTK.F invest in?

Tracks Morningstar Gbl Biotechnology NR USD
  • Mostly US stocks (91.1%)
  • Largest sector: Healthcare (100.0%)
  • Largest region: North America (97.9%)

Asset allocation

  • US stocks 91.1%
  • Non-US stocks 7.3%

Invesco NASDAQ Biotech UCITS ETF performance

Sharpe ratio 0.92
This year
+34.65%
1 year
+43.59%
3 years
+24.38%
5 years
+9.42%

Volatility 18.1% over 1 year and 18.5% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

NBTK.F price

Prices on the chart can differ slightly from the closing prices StockSummer shows.